78608

Brain imaging, positron emission tomography (PET); metabolic evaluation

CPT code 78608 describes a specialized nuclear medicine procedure involving positron emission tomography (PET) of the brain for the purpose of metabolic evaluation. This imaging modality is primarily used to assess regional cerebral glucose metabolism, providing a functional map of brain activity that structural imaging like MRI or CT cannot offer. The procedure typically utilizes the radiopharmaceutical F-18 fluorodeoxyglucose (FDG), which is a glucose analog. Because the brain relies heavily on glucose for energy, the uptake and distribution of FDG serve as a direct indicator of neuronal and synaptic function. The clinical utility of this procedure is vast, particularly in the differential diagnosis of neurodegenerative disorders. For instance, in Alzheimer's disease, the metabolic PET scan often reveals a characteristic pattern of hypometabolism in the temporoparietal regions, whereas in frontotemporal dementia, the deficits are concentrated in the frontal and anterior temporal lobes. Furthermore, 78608 is a critical tool in the management of refractory epilepsy, where it is used interictally to identify areas of decreased metabolism that correspond to the epileptogenic focus for potential surgical resection. In the field of oncology, this procedure helps clinicians distinguish between recurrent primary brain tumors or metastases and post-treatment effects such as radiation necrosis, as viable malignant cells demonstrate high metabolic activity while necrotic tissue does not. The study involves a careful preparation phase where the patient's blood glucose is monitored, followed by a tracer injection and a strictly controlled resting period in a low-stimulus environment to prevent artifactual tracer uptake. The resulting three-dimensional images allow for both qualitative visual inspection and quantitative metabolic assessment.

Clinical Indications

  • Differential diagnosis of dementias (e.g., Alzheimer's vs. Frontotemporal)
  • Pre-surgical evaluation of medically refractory epilepsy to localize foci
  • Evaluation of suspected brain tumor recurrence versus radiation necrosis
  • Assessment of cognitive decline or mild cognitive impairment (MCI)
  • Evaluation of primary central nervous system (CNS) lymphoma
  • Assessment of atypical Parkinsonian syndromes
  • Evaluation of metabolic changes in various encephalopathies

Procedure Steps

  1. Verification of patient fasting status (typically 4-6 hours) and blood glucose level (ideally <200 mg/dL).
  2. Establishment of intravenous (IV) access.
  3. Administration of the radiopharmaceutical, typically F-18 FDG (Fluorodeoxyglucose).
  4. Uptake period of 30 to 60 minutes where the patient remains in a dark, quiet room with minimal sensory input.
  5. Patient positioning in the PET or PET/CT scanner with the head immobilized.
  6. Acquisition of emission images (typically 15-30 minutes of scanning time).
  7. Reconstruction of data using attenuation correction techniques (often utilizing a low-dose CT).
  8. Processing of axial, sagittal, and coronal slices for physician interpretation and quantitative analysis.

Coding Guidelines

  • Do not report code 78608 in conjunction with code 78609 (Brain imaging, PET; perfusion evaluation).
  • The radiopharmaceutical used (e.g., A9552 for FDG) is typically billed separately in the outpatient hospital or clinic setting.
  • If the PET scan is performed on a PET/CT scanner, the CT portion used for attenuation correction and anatomical registration is included and not separately reportable.
  • A diagnostic CT scan performed concurrently with PET may be billed separately only if it meets criteria for a full diagnostic study (e.g., with contrast, documented separately).
  • Append modifier 26 if only the professional component (interpretation) is being billed, or modifier TC if only the technical component is being billed.
  • Ensure the clinical documentation supports the medical necessity as per local carrier determinations (LCDs), especially for dementia indications.

Associated ICD-10 Codes